查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424309

全球经肠营养製剂市场：按产品类型、按流程类型、按阶段、按适应症、按最终用途、按销售管道、按地区

Global Enteral Feeding Formulas Market, By Product, By Flow Type, By Stage, By Indication, By End Use (Hospitals, Home Care), By Sales Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

经肠营养製剂的全球市场规模预计将从 2023 年的 57.9 亿美元增至 2030 年的 109.4 亿美元，预测期内复合年增长率为 9.5%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 57.9亿美元
过去的资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 9.50% 2030/2031价值预测 109.4亿美元
图 1. 2023 年经肠营养产品的全球市场占有率（按地区划分）
全球肠内餵食配方奶粉市场-IMG1

经肠营养製剂食品直接给予无法充分口服摄取的人的胃、十二指肠或空肠的营养补充。经肠营养製剂有许多不同类型。以蛋白质为主要营养素的经肠营养配方食品，适用于需要补充营养但碳水化合物或脂肪摄取量极少的人。标准经肠营养配方含有均衡的碳水化合物、蛋白质和脂肪组合。这些配方可以满足您大部分日常营养需求，适合长期使用。特异性疾病的处方是针对特定的健康状况而量身定制的，例如糖尿病、肾衰竭或肝病。含膳食纤维製剂含有可溶性和不可溶性膳食纤维，可促进肠道正常功能。

每种类型都有优点和缺点。以蛋白质为基础的配方奶粉有助于满足蛋白质需求，而不会摄取过多的热量，但它们缺乏均衡的营养。标准配方奶粉提供均衡的营养，但可能无法满足特殊的用餐需求。针对特异性疾病的配方可满足特定疾病的独特营养需求，但价格昂贵。含有膳食纤维的配方奶有助于规律排便，但更浓稠且热量更高。应根据个人的健康状况、营养需求和耐受性选择合适的治疗方案。经肠营养可以确保无法透过口服摄取营养的患者获得充足的营养。

市场动态：.

全球经肠营养产品市场是由老年人口增加、慢性病患病率增加、早产数量增加以及成人吞嚥困难迅速增加所推动的。根据联合国的预测，到2050年，60岁及以上的人口将增加近一倍，超过年轻人口。老年人更有可能出现需要经肠营养支持的疾病，例如失智症或手术后併发症。此外，国际上需要经肠营养支持的慢性疾病的数量正在增加，例如癌症、神经系统疾病和胃肠道疾病。这对市场成长产生正面影响。然而，替代输送方法的可用性、与管相关的感染风险以及特种配方的高成本正在限制市场成长。有机、非基因改造和无过敏原配方的市场开拓为市场参与者提供了利润丰厚的机会。

本研究的主要特点

  • 本报告对全球经肠营养製剂市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它揭示了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球经肠营养製剂市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球经肠营养製剂市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球经肠营养製剂市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 服务交付组合
  • PEST分析
  • 波特的分析
  • 併购场景
  • 管道分析

第四章全球经肠营养製剂市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球经肠营养製剂市场（依产品），2018-2030

  • 标准配方
  • 疾病专科配方
  • 元素公式
  • 特殊配方

第六章全球经肠营养製剂市场，依流程类型，2018-2030

  • 间歇性的
  • 间歇性的

第七章 2018-2030 年全球经肠营养製剂市场（按阶段）

  • 成人
  • 儿童

第 8 章全球经肠营养製剂市场（按适应症）2018-2030 年

  • 阿兹海默症
  • 营养不良
  • 癌症治疗
  • 糖尿病
  • 慢性肾臟病
  • 孤儿病
  • 吞嚥困难
  • 疼痛管理
  • 其他（吸收不良/胃肠道疾病/腹泻等）

第 9 章全球经肠营养製剂市场，依最终用户划分，2018-2030 年

  • 医院
  • 心臟病学
  • 神经病学
  • 重症监护（ICU）
  • 肿瘤学
  • 其他的
  • 居家护理

第10章全球经肠营养製剂市场，依销售管道，2018-2030

  • 网上销售
  • 零售销售
  • 企业销售

第十一章全球经肠营养製剂市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第十二章竞争形势

  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Mead Johnson & Company, LLC
  • Abbott
  • Danone SA
  • Fresenius Kabi AG

第13章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6515

The Global Enteral Feeding Formulas Market size is expected to reach US$ 10.94 Bn by 2030, from US$ 5.79 Bn in 2023, exhibiting a CAGR of 9.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 5.79 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 9.50% 2030/2031 Value Projection: US$ 10.94 Bn
Figure 1. Global Enteral Feeding Formulas Market Share (%), By Region, 2023
Global Enteral Feeding Formulas Market - IMG1

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics:

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global enteral feeding formulas market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market

Global Enteral Feeding Formulas Market Detailed Segmentation:

  • By Product
    • Standard Formula
    • Disease-specific Formulas
    • Elemental Formulas
    • Specialized Formulas
  • By Flow Type
    • Intermittent Feeding Flow
    • Continuous Feeding Flow
  • By Stage
    • Adults
    • Pediatrics
  • By Indication
    • Alzheimer's
    • Nutrition Deficiency
    • Cancer Care
    • Diabetes
    • Chronic Kidney Diseases
    • Orphan Diseases
    • Dysphagia
    • Pain Management
    • Others (Malabsorption/GI Disorder/Diarrhea, etc.)
  • By End Use
    • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
    • Home Care
  • By Sales Channel
    • Online Sales
    • Retail Sales
    • Institutional Sales
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Key Players
    • Nestle
    • VICTUS
    • Primus Pharmaceuticals, Inc.
    • Meiji Holdings. Co., Ltd.
    • Mead Johnson & Company, LLC
    • Abbott
    • Danone S.A
    • Fresenius Kabi AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Enteral Feeding Formulas Market, By Product
    • Global Enteral Feeding Formulas Market, By Flow Type
    • Global Enteral Feeding Formulas Market, By Stage
    • Global Enteral Feeding Formulas Market, By Indication
    • Global Enteral Feeding Formulas Market, By End User
    • Global Enteral Feeding Formulas Market, By Sales Channel
    • Global Enteral Feeding Formulas Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of chronic diseases
    • Changes in healthcare landscape and reimbursement policies
    • Increasing preference for homecare services
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Enteral Feeding Formulas Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Enteral Feeding Formulas Market, By Product, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Standard Formula
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Disease-specific Formulas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Elemental Formulas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Specialized Formulas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Enteral Feeding Formulas Market, By Flow Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Intermittent Feeding Flow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Continuous Feeding Flow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Enteral Feeding Formulas Market, By Stage, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Enteral Feeding Formulas Market, By Indication, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alzheimer's
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Nutrition Deficiency
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cancer Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Chronic Kidney Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Orphan Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Dysphagia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Malabsorption/GI Disorder/Diarrhea, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Enteral Feeding Formulas Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
  • Home Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Global Enteral Feeding Formulas Market, By Sales Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Online Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Institutional Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

11. Global Enteral Feeding Formulas Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

12. Competitive Landscape

  • Nestle
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Mead Johnson & Company, LLC
  • Abbott
  • Danone S.A
  • Fresenius Kabi AG
  • Analyst Views

13. Section

  • Research Methodology
  • About us